Zimmer Biomet Holdings (ZBH) EBT Margin Growth (3y) (2012 - 2026)

Zimmer Biomet Holdings (ZBH) EBT Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 183.06 Bn 175.76 Bn 6.27 Bn -305.00
2 Stryker 128.66 Bn 125.78 Bn 3.81 Bn -9.00
3 Medtronic 108.82 Bn 99.60 Bn 6.41 Bn 55.00
4 Boston Scientific 68.43 Bn 66.98 Bn 3.61 Bn 923.00
5 Edwards Lifesciences 48.29 Bn 44.61 Bn 1.29 Bn -480.00
6 GE HealthCare Technologies 28.37 Bn 26.08 Bn 1.98 Bn -176.00
7 Dexcom 28.29 Bn 27.18 Bn 750.30 Mn 1,391.00
8 Smith & Nephew 26.89 Bn 26.31 Bn - -
9 Koninklijke Philips 25.43 Bn 22.31 Bn 2.07 Bn 2,114.00
10 Zimmer Biomet Holdings 18.10 Bn 17.68 Bn 1.51 Bn -122.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -122.00
Dec 31, 2025 -4,752.00
Sep 30, 2025 331.00
Jun 30, 2025 -38.00
Mar 31, 2025 591.00
Dec 31, 2024 1,498.00
Sep 30, 2024 131.00
Jun 30, 2024 546.00
Mar 31, 2024 -198.00
Dec 31, 2023 -283.00
Sep 30, 2023 -76.00
Jun 30, 2023 3,290.00
Mar 31, 2023 4,391.00
Dec 31, 2022 -442.00
Sep 30, 2022 88.00
Jun 30, 2022 414.00
Mar 31, 2022 -868.00
Dec 31, 2021 233.00
Sep 30, 2021 295.00
Jun 30, 2021 -75.00